Skip to content
★ Sign in to follow
PH

ProBiotix Health plc Stock: price and insider trades · United Kingdom

ISIN GB00BLNBFR86GB·Mcap £12.3MHealth Care

No insider purchase over the last 90 days. The latest, by Adam Reynolds, was filed 04 Feb 2026.

ProBiotix Health plc: what insiders have been doing

Every trade that managers of ProBiotix Health plc disclose to RNS (LSE) is tracked on this page. The company sits in the Health Care sector. From 25 October 2025 to 25 October 2026, the disclosure feed for ProBiotix Health plc logged 1 filing by 1 insider.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 board member.

The last insider purchase was made public on 4 February 2026, 277 days ago.

With 1 filing in twelve months, the company is quieter than the median of 6 filings across the 832 companies we follow on the same exchange. The full history, which starts in 2024, counts 4 purchases against no sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Adam Reynolds2 buys
Mads Brandt1 buy
Fundamental score
Ranked 23,363 of 26,914 companies
25.0
score / 100
Value
22
Quality
28
FCF yld-3.1%
Earn yld-10%
EV/EBITDA·
ROE-73%
Gross mgn54%
Net mgn-45%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

£0.08
Analyst consensus
·
Income statement
Revenue£2.7M
Gross profit£1.5M54% margin
EBITDA-£1.2M-43% margin
Net income-£1.2M-45.1% margin
Valuation
P/Book861.1x
Beta0.02
Balance sheet & cash
Market cap£12.3M
Free Cash Flow-£379k
Profitability & ownership
ROE-73.3%
ROA-38.7%
% insiders29.4%
% institutions5.0%
Last declaration on 4 February 2026
Declarations4 total
  • ▲
    ChairmanExecutives
    0RNS
    0Aquis Growth MarketISIN GB00BLNBFR86RNS:09afb172-9061-4092-9773-01f3d338b444
    Canonical exit: 4 May 2026 (T+90)
  • ▲
    ChairmanExecutives
    0RNS
    0Aquis Growth MarketISIN GB00BLNBFR86RNS:5860853
    Canonical exit: 12 Jan 2026 (T+90)
  • ▲
    Head of Supply ChainExecutives
    0RNS
    0Aquis Growth MarketISIN GB00BLNBFR86RNS:5674438
    Canonical exit: 27 Aug 2025 (T+90)
  • ▲
    Company SecretaryExecutives
    0RNS
    0Aquis Growth MarketISIN GB00BLNBFR86RNS:5417940
    Canonical exit: 30 Jan 2025 (T+90)

4 of 4 declarations

About ProBiotix Health plc

ProBiotix Health plc is a company focused on developing health products based on probiotics. It concentrates on innovation in the fields of digestive and cardiovascular health.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations